130 related articles for article (PubMed ID: 9620028)
1. The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: a prospective study of 52 patients.
Chen LM; Lazcano O; Katzmann JA; Kimlinger TK; Li CY
Am J Clin Pathol; 1998 Jun; 109(6):712-21. PubMed ID: 9620028
[TBL] [Abstract][Full Text] [Related]
2. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
[TBL] [Abstract][Full Text] [Related]
3. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
4. DNA Ploidy Analysis and Cell Block Immunohistochemistry in the Diagnosis of Malignant Effusions.
Puri M; Sen R; Gupta M; Kalra R; Bhargava S; Puri K
Acta Cytol; 2020; 64(3):256-264. PubMed ID: 31466063
[TBL] [Abstract][Full Text] [Related]
5. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DNA flow cytometric analysis of body cavity fluids with conventional cytology.
Lima CE; Mizushima Y; Masuda S; Kitagawa M
In Vivo; 1994; 8(3):359-62. PubMed ID: 7803718
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
Sayed DM; el-Attar MM; Hussein AA
Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
9. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.
Frierson HF; Mills SE; Legier JF
Am J Clin Pathol; 1988 Sep; 90(3):240-3. PubMed ID: 3414598
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
12. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
Nieh S; Chen SF; Fu E; Jan CI; Lee WH
Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
[TBL] [Abstract][Full Text] [Related]
13. Flow immunocytochemistry of marker expression in cells from body cavity fluids.
Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M
Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
Sikora J; Dworacki G; Zeromski J
Lung; 1996; 174(5):303-13. PubMed ID: 8843056
[TBL] [Abstract][Full Text] [Related]
16. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
Ruitenbeek T; Gouw AS; Poppema S
Arch Pathol Lab Med; 1994 Mar; 118(3):265-9. PubMed ID: 8135629
[TBL] [Abstract][Full Text] [Related]
17. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids.
Bisht B; Handa U; Mohan H; Lehl SS
Malays J Pathol; 2014 Aug; 36(2):83-90. PubMed ID: 25194530
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of cytodiagnosis of body fluids in a laboratory of urgencies.
Rocher AE; Guerra F; Rofrano J; Angeleri A; Canessa OE; Mendeluk GR; Palaoro LA
Biotech Histochem; 2011 Oct; 86(5):326-32. PubMed ID: 20961211
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids.
Katz RL; Johnson TS; Williamson KD
Anal Quant Cytol Histol; 1985 Sep; 7(3):227-35. PubMed ID: 4052224
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids.
Sinton EB; Carver RK; Morgan DL; Philpott PJ; Truell JE; Riemann D; Ashton ME
Arch Pathol Lab Med; 1990 Feb; 114(2):188-94. PubMed ID: 2302036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
